Viewing StudyNCT03571633



Ignite Creation Date: 2024-05-06 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 12:48 PM
Study NCT ID: NCT03571633
Status: RECRUITING
Last Update Posted: 2023-01-10
First Post: 2018-06-04

Brief Title: Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2 Breast Cancer Breast Cancer
Sponsor: Centre Leon Berard
Organization: Centre Leon Berard

Conditions & Keywords Data

Conditions:
Name
Operable Breast Cancer
HER2-positive Breast Cancer
Keywords:
Name View
Antibody-dependent cell-mediated cytotoxicity View
Pegfilgrastim View
TrastuzumabPaclitaxel View